BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech

Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced a collaboration with Biosero, a developer of laboratory automation solutions, to enable and facilitate robotic arm integration with BD flow cytometry instruments. This partnership aims to enhance the precision and efficiency of drug discovery and development processes, enabling researchers to streamline workflows and improve data accuracy.The integration leverages Biosero’s advanced automation software with BD’s flow cytometers, ...